Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

Appendicitis - Antibiotics or Appendectomy?

Facilitated Diffusion of Proline across Membranes of Liposomes and Living Cells by a Calix[4]pyrrole Cavitand

Can PRESENCEOF HYALURONAN be used as a  treatment option in COVID19 patients?
  • BiotechToday
  • World

Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

bioxone October 7, 2020October 7, 2020

Arpita Adhikary, Amity University Kolkata

Deterioration of the respiratory system mainly the lungs is prominent in SARS COVID-19. An active agent, a jelly-like substance was found in dead COVID 19 patients’ respiratory system.

 A novel fact is established by the researchers as they conducted an experiment comparing the diseased lung tissue of COVID patients and normal lung tissue. This experiment was done to identify the presence of jelly which is known as hyaluronan, a polysaccharide in the glycosaminoglycan group as hyaluronan can be a reason for respiratory inflammation and blockage.

So a group of researchers took autopsy of three lung tissue samples of COVID 19 patients and processed hyaluronan histochemistry along with a direct staining method to distinguish the presence of hyaluronan from normal lung tissues, stained by normal staining. This report confirms that hyaluronan presents in the form of exudates and plugs, obstructing the alveoli to perform. On the other side, Hyaluronan presents only in intact alveolar walls and perivascular tissue in the normal sample.

This up to date discovery can be used to find alternative effective therapies such as different enzymes which can be used to break hyaluronan.

Also read: Appendicitis – Antibiotics or Appendectomy?

Source: https://www.jbc.org/content/early/2020/09/25/jbc.AC120.015967

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged alternate effective therapies autopsy blockage Covid enzymes Hyaluronan inflammation jelly like substance lung tissue polysaccharides

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Facilitated Diffusion of Proline across Membranes of Liposomes and Living Cells by a Calix[4]pyrrole Cavitand

bioxone October 7, 2020

Parnad Basu, Amity University Kolkata The metabolism of cells, transporting amino acids across the cell’s membrane is an integral part of the process. Many pieces of research suggest that serious diseases like cancer (abnormal cell division), cystic fibrosis (a hereditary disease affecting the lungs and digestive system), aminoaciduria (urine contains a high number of amino […]

Calix[4]pyrrole

Related Post

  • BiotechToday
  • World

A drug to reduce Covid infection by 99%

BioTech Today June 29, 2021June 28, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Haploflow: Tracing the disease back to its Origin

BioTech Today July 22, 2021July 21, 2021

Agrima Bhatt, Rajasthan University In the last few decades, humankind has gone through major healthcare upheavals causing a large amount of death and destruction. Epidemics, pandemics have come, some have passed with time but some have evolved to stay. And as we continue forward, scientists are already predicting the next pandemic to come soon. In […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A relaxin based nanoparticle treats liver fibrosis

bioxone January 29, 2021January 29, 2021

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Liver fibrosis is one of the leading causes of morbidity and mortality among human beings. The unavailability of proper antifibrotic therapy makes the disease more deadly and the patients more vulnerable. RLX ( peptide hormone human relaxin-2), acting through a G protein-coupled receptor relaxin peptide receptor 1 (RXFP1), promotes tissue […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy